Elevated lipogenesis, thought to initiate NAFLD and contribute markedly to hepatic steatosis19,20, has long been proposed to be triggered by overactivation of SREBP1, the major transcriptional regulator of lipid biosynthesis and a FBXW7 substrate11,13. Here, FBXW7 is linked to metabolic dysfunction-associated steatotic liver disease.